Omada Health delivered a strong fourth quarter, achieving its first period of positive GAAP net income and positive Adjusted EBITDA. Revenue grew 58% year-over-year driven by significant member growth and expansion in GLP-1 companion support services. The company also improved its gross margin to 71% and ended the year with a robust cash position following its IPO.